VBI Vaccines
VBIV
#10531
Rank
โ‚ฌ1.59 M
Marketcap
0,05562ย โ‚ฌ
Share price
0.00%
Change (1 day)
-90.42%
Change (1 year)

Earnings for VBI Vaccines (VBIV)

Earnings in 2024 (TTM): -โ‚ฌ76.8 Million

According to VBI Vaccines 's latest financial reports the company's current earnings are โ‚ฌ9.41 Million. In 2023 the company made an earning of -โ‚ฌ79.08 Million, an increase over its 2022 earnings that were of -โ‚ฌ96.52 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for VBI Vaccines from 1998 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ76.8 Million-2.89%
2023 -โ‚ฌ79.08 Million-18.06%
2022 -โ‚ฌ96.52 Million62.43%
2021 -โ‚ฌ59.42 Million50.88%
2020 -โ‚ฌ39.38 Million-15.66%
2019 -โ‚ฌ46.69 Million-13.82%
2018 -โ‚ฌ54.18 Million61.32%
2017 -โ‚ฌ33.59 Million57.8%
2016 -โ‚ฌ21.29 Million-67.39%
2015 -โ‚ฌ65.27 Million1527.36%
2014 -โ‚ฌ4.02 Million36.21%
2013 -โ‚ฌ2.95 Million-63.91%
2012 -โ‚ฌ8.16 Million-59.19%
2011 -โ‚ฌ20 Million227.23%
2010 -โ‚ฌ6.11 Million1741.53%
2009 -โ‚ฌ0.34 Million14.52%
2008 -โ‚ฌ0.29 Million-42.93%
2007 -โ‚ฌ0.51 Million21.8%
2006 -โ‚ฌ0.42 Million172.39%
2005 -โ‚ฌ0.16 Million115.38%
2004 -โ‚ฌ0.08 Million-42.27%
2003 -โ‚ฌ0.13 Million109.27%
2002 -โ‚ฌ0.06 Million17.89%
2001 -โ‚ฌ0.05 Million-369.64%
2000 โ‚ฌ0.01 M-69.24%
1999 โ‚ฌ0.06 M12.77%
1998 โ‚ฌ0.05 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-โ‚ฌ15.47 Million-78.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-โ‚ฌ0.36 Billion 404.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-โ‚ฌ27.74 Million-60.77%๐Ÿ‡บ๐Ÿ‡ธ USA